Report of Phase Ⅱ Clinical Trial of Aikang Capsule (Ginsenoside Rg3)
Aikang Capsule (Ginsenoside Rg3) is a secret product of No.1 innovative Chinese medicine declared by Natural Medicine Research Institute of Tianfu Technology Development Company in Dalian Development Area. It has been proved in the preclinical pharmacodynamic experiment that combing with anti-tumor chemotherapy, ginsenoside Rg3 could enhance antitumor effect, reduce side effects and promote the immune function and prevent the invasion and metastasis. Its fit for tumor patients with Qi deficiency syndrome. The Phase Ⅰ clinical trial has been accomplished, and its been proved the safety and free of side effect within effective dosage. Phase Ⅱ clinical trial has been approved by the Bureau of Drug Administration of Health Ministry and carried on by Guangan Men Hospital, China Academy of Chinese Medical Sciences (the clinical pharmacological base of the Ministry of Health). The approved document number is (clinical medicine applying number)97No. ZL-77. According to the Evaluation Method of National New Product of Chinese Medicine and the Principles on Clinical Researches with Chinese Materia Medica and New medinine, Guangan Men Hospital organized 5 hospitals above provincial level from May 1998 to April 1999 to perform Phase Ⅱ clinical trial, in order to evaluate the curative effect, safety and side effect of the drug scientifically. The 5 hospitals included Changzheng Hospital of Second Military Medical University, Affiliated Hospital of Anhui Medical University,the clinical pharmacological base of the Ministry of Health in Tianjin Tumor Hospital, the clinical pharmacological base of Dalian Medical Univeristy and Cancer Hospital of Heilongjiang Province.
Bingkui Piao Hongsheng Lin Guangru Xie Mingchen Zhou Guangjie Sui Jiejun Wang Zhendong Chen Jiwei Liu
Guangan Men Hospital,China Academy of Chinese Medical Sciences the clinical pharmacological base of the Ministry of Health
国际会议
2008 International Conference on Ginseng(2008国际人参会议)
长春
英文
116-131
2008-09-01（万方平台首次上网日期，不代表论文的发表时间）